Advent Clinical Research Sarasota, FL - 34243

Advent Clinical Research is categorized under Research and Development Laboratories in Sarasota, FL and active since 2013.

Advent Clinical Research was established in 2013, and today employs 1 to 4, earning Unknown per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 5419100 by the NAICS.

If you are seeking more information, feel free to contact Patricia Timm, Director at the company’s single location by writing to 2401 University Parkway # 106, Sarasota, Florida FL 34243 or by phoning (941) 351-5282. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Advent Clinical Research
Contact Person: Patricia Timm, Director
Address: 2401 University Parkway # 106, Sarasota, Florida 34243
Phone Number: (941) 351-5282
Annual Revenue (USD): Unknown
Founded: 2013
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Research and Development Laboratories
SIC Code: 8731
NAICS Code: 5419100
Share This Business:

Advent Clinical Research was started in 2013 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Patricia Timm, Director for inquiries that concern Advent Clinical Research by calling the company number (941) 351-5282, as your correspondence is most welcome. Additionally, the physical location of the single location of Advent Clinical Research can be found at the coordinates 27.38908,-82.52126 as well as the street address 2401 University Parkway # 106 in Sarasota, Florida 34243.

For its online presence, you may visit Advent Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.